HIFU-FACET: MR-HIFU for Non-invasive Thermal Therapy of Facet-Joint Syndrome:

Sponsor
Universitätsklinikum Köln (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05436873
Collaborator
German Federal Ministry of Education and Research (Other)
10
1
1
23.7
0.4

Study Details

Study Description

Brief Summary

Patients suffering from facet-joint-syndrome associated with lower-back pain will be treated with MRI-guided High Intensity Focused Ultrasound thermal therapy for pain relief.

Condition or Disease Intervention/Treatment Phase
  • Device: MR-HIFU
N/A

Detailed Description

Patients with diagnosed facet-joint-syndrome are suffering from severe pain in the respective regions, mainly lower-back pain. Eligible patients will be treated with High Intensity Focused Ultrasound (HIFU) under MRI control. The control by MRI assures on the one hand the correct selection of area to be sonicated and monitors in parallel the temperature, reached in the target area. The aim is to thermally ablate facet joint and/or medial branch nerves at lumbar spine. Ablation is deemed to be feasible and successful if temperatures of at least 57°C are reached at the target. The entire procedure will be done under anaesthesia.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
There is only 1 treatment arm, as this is a feasibility study.There is only 1 treatment arm, as this is a feasibility study.
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Evaluation of Sonalleve MR-HIFU for Non-invasive Thermal Therapy of Facet-Joint Syndrome: Feasibility and Safety Clinical Study
Actual Study Start Date :
Jun 10, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment Arm

This is a single arm study

Device: MR-HIFU
MRI guided High Intensity Focused Ultrasound sonication.

Outcome Measures

Primary Outcome Measures

  1. Feasibility: planned temperature (57°C) achieved at target area of sonication [treatment day (4 hours)]

    Temperatures achieved at the intended treatment location during MR-HIFU treatments

Secondary Outcome Measures

  1. safety of entire procedure [180 days]

    Frequency and severity of adverse events associated with use of the Sonalleve MR-HIFU system

  2. Pain reduction after study treatment [180 days]

    pain reduction as shown in VAS and change in frequency/type/dosing of pain relief medication

  3. change in Quality of Life (QoL) assessed via Quality of Life Questionnaire [180 days]

    The change in QoL scores throughout study participation [as higher values, as better quality of Life]

  4. comparison of contrast in MRI before and after treatment [180 days]

    Qualitative analysis of the change in image tissue contrast in MRI images taken prior, during and after the treatment. This is a visual evaluation only.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • chronic low back pain

  • clinical diagnosis of Lumbar Facet Joint Syndrome

  • eligible for MRI and MR-HIFU session

  • eligible for general anaesthesia

  • intact skin and soft tissue over treatment zone

  • facet joint anatomy clearly identifiable

  • patients must be able to discontinue all pain relief medication for a minimum of 48 hours prior to baseline assessment

  • patients able to provide consent for the study

Exclusion Criteria:
  • spinal implants

  • treatment target zone < 10 mm from the skin

  • pregnant female patients

  • breastfeeding female patients

  • body weight > 140 kg

  • systemic and/or local infections

  • moderate to high grade of spinal instability

  • MRI contrast agent contraindication

  • any MRI-unsafe implant or pacemaker

  • facet joint anatomy which is not targetable or reachable due to scars, surgical clips, implants, or prosthesis in the planned beam path of the ultrasound beam

Contacts and Locations

Locations

Site City State Country Postal Code
1 Holger Gruell Cologne Germany 50937

Sponsors and Collaborators

  • Universitätsklinikum Köln
  • German Federal Ministry of Education and Research

Investigators

  • Principal Investigator: Kourosh Zarghooni, PD, Department of Orthopaedics and Trauma Surgery; Cologne University Hospital; Kerpener Strasse 62; D 50937 Cologne

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universitätsklinikum Köln
ClinicalTrials.gov Identifier:
NCT05436873
Other Study ID Numbers:
  • Uni-Koeln-4473
First Posted:
Jun 29, 2022
Last Update Posted:
Jul 6, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2022